My Account
Log in Registration
All
Cart
Highlights
Fiction Books
Non-Fiction Books
Children's Books
Rare Books
Music
DVD & Blu-Ray
Video Games
Category
Wishlists
Cart
All
Free US shipping over $10
Trustpilot
Proud to be B-Corp

Red Book (R) David W. Kimberlin

Red Book (R) By David W. Kimberlin

Red Book (R) by David W. Kimberlin

Reviews:
$4.67
Condition - Good
Only 1 left
Good

Summary

This convenient flip chart provides paediatric health care professionals with point-of-care guidance on the assessment, prevention, and treatment of childhood infectious diseases. Includes handy algorithms and tables to provide quick, practical support and guidance.

Faster Shipping

Get this product faster from our US warehouse

Red Book (R) Summary

Red Book (R): Pediatric Infectious Diseases Clinical Decision Support Chart by David W. Kimberlin

This convenient flip chart provides pediatric health care professionals with point-of-care guidance on the assessment, prevention, and treatment of childhood infectious diseases. Includes handy algorithms and tables to provide quick, practical support and guidance.

Topics include:
  • Syphilis
  • Varicella-Zoster Virus
  • Zika
  • Immunizations
  • S Aureus Infections
  • Genital Herpes and Neonates
  • Tuberculosis
  • Streptococcal Infections
  • Fungal Infections
  • Procedural Prophylaxis
  • Lyme Disease
  • Immunocompromised Children and Adolescents
  • Diarrheal Infections
  • Epstein-Barr Virus
  • Kawasaki Disease

About David W. Kimberlin

David W. Kimberlin, MD, FAAP is the Principal Investigator for the Collaborative Antiviral Study Group (CASG), an international network of pediatric academic medical centers that evaluates antiviral therapeutics in rare diseases with a large unmet medical need, including neonatal herpes simplex virus (HSV) infections, congenital cytomegalovirus (CMV) disease, congenital Zika infection, neonatal and infantile influenza infection, and neonatal enteroviral sepsis syndrome. Studies conducted by the CASG have led to new drug indications and label changes for acyclovir, valganciclovir, and oseltamivir, and non-CASG studies conducted by Dr. Kimberlin also have led to label changes for valacyclovir.

Dr. Kimberlin is Editor of the 2018 AAP Report of the Committee on Infectious Diseases (Red Book). He also was Editor of the 2015 edition, and was an Associate Editor of the 2012 and 2009 editions. Dr. Kimberlin is a Past-President of the Pediatric Infectious Diseases Society (PIDS), which is the world's largest organization of professionals dedicated to the treatment, control, and eradication of infectious diseases affecting children. He also serves as Vice Chair for Clinical and Translational Research in the UAB Department of Pediatrics, where he holds the Sergio Stagno Endowed Chair in Pediatric Infectious Diseases and is Co-Director of the Division of Pediatric Infectious Diseases.

Additional information

CIN1610023056G
9781610023054
1610023056
Red Book (R): Pediatric Infectious Diseases Clinical Decision Support Chart by David W. Kimberlin
David W. Kimberlin
Used - Good
Hardback
American Academy of Pediatrics
20181030
34
N/A
Book picture is for illustrative purposes only, actual binding, cover or edition may vary.
This is a used book - there is no escaping the fact it has been read by someone else and it will show signs of wear and previous use. Overall we expect it to be in good condition, but if you are not entirely satisfied please get in touch with us

Customer Reviews - Red Book (R)